tetano
Editor, Senior Moderator
Diabetes Obes Metab
. 2023 Apr 4.
doi: 10.1111/dom.15076. Online ahead of print.
A UK nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID-19
Benjamin C T Field[SUP] 1 2 [/SUP], Yue Ruan[SUP] 3 4 [/SUP], Kinga A Várnai[SUP] 4 5 [/SUP], Jim Davies[SUP] 4 6 [/SUP], Robert E J Ryder[SUP] 7 [/SUP], Rajiv Gandhi[SUP] 8 [/SUP], Sophie Harris[SUP] 9 [/SUP], Dinesh Nagi[SUP] 10 [/SUP], Dipesh Patel[SUP] 11 [/SUP], Punith Kempegowda[SUP] 12 13 [/SUP], Sarah H Wild[SUP] 14 [/SUP], Emma G Wilmot[SUP] 15 16 [/SUP], Kamlesh Khunti[SUP] 17 [/SUP], Rustam Rea[SUP] 3 4 [/SUP], Parth Narendran[SUP] 12 13 [/SUP]; ABCD COVID-19 audit group
Collaborators, Affiliations
Abstract
Aims: To investigate characteristics of people hospitalised with coronavirus-disease-2019 (COVID-19) and diabetic ketoacidosis (DKA) or hyperosmolar hyperglycaemic state (HHS), and to identify risk factors for mortality and intensive care admission.
Materials and methods: Retrospective cohort study with anonymised data from the Association of British Clinical Diabetologists nationwide audit of hospital admissions with COVID-19 and diabetes, from start of pandemic to November 2021. Primary outcome was inpatient mortality. DKA and HHS were adjudicated against national criteria. Age-adjusted odds ratios (ORs) were calculated using logistic regression.
Results: 85 confirmed DKA cases, and 20 HHS, occurred among 4073 people (211 type 1 diabetes, 3748 type 2 diabetes, 114 unknown type) hospitalised with COVID-19. Mean(SD) age was 60(18.2)y in DKA and 74(11.8)y in HHS (P < 0.001). A higher proportion of patients with HHS than with DKA were of non-White ethnicity (71.4% vs 39.0% P = 0.038). Mortality in DKA was 36.8% (n = 57) and 3.8% (n = 26) in type 2 and type 1 diabetes respectively. Among people with type 2 diabetes and DKA, mortality was lower in insulin users compared to non-users (21.4% vs. 52.2%; age-adjusted OR 0.13 [95%CI 0.03-0.60]). Crude mortality was lower in DKA than HHS (25.9% vs. 65.0%, P = 0.001) and in statin users vs non-users (36.4% vs. 100%; P = 0.035) but these were not statistically significant after age adjustment.
Conclusions: Hospitalisation with COVID-19 and adjudicated DKA is four times more common than HHS but both associate with substantial mortality. There is a strong association of prior insulin therapy with survival in type 2 diabetes-associated DKA. This article is protected by copyright. All rights reserved.
. 2023 Apr 4.
doi: 10.1111/dom.15076. Online ahead of print.
A UK nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID-19
Benjamin C T Field[SUP] 1 2 [/SUP], Yue Ruan[SUP] 3 4 [/SUP], Kinga A Várnai[SUP] 4 5 [/SUP], Jim Davies[SUP] 4 6 [/SUP], Robert E J Ryder[SUP] 7 [/SUP], Rajiv Gandhi[SUP] 8 [/SUP], Sophie Harris[SUP] 9 [/SUP], Dinesh Nagi[SUP] 10 [/SUP], Dipesh Patel[SUP] 11 [/SUP], Punith Kempegowda[SUP] 12 13 [/SUP], Sarah H Wild[SUP] 14 [/SUP], Emma G Wilmot[SUP] 15 16 [/SUP], Kamlesh Khunti[SUP] 17 [/SUP], Rustam Rea[SUP] 3 4 [/SUP], Parth Narendran[SUP] 12 13 [/SUP]; ABCD COVID-19 audit group
Collaborators, Affiliations
- PMID: 37016487
- DOI: 10.1111/dom.15076
Abstract
Aims: To investigate characteristics of people hospitalised with coronavirus-disease-2019 (COVID-19) and diabetic ketoacidosis (DKA) or hyperosmolar hyperglycaemic state (HHS), and to identify risk factors for mortality and intensive care admission.
Materials and methods: Retrospective cohort study with anonymised data from the Association of British Clinical Diabetologists nationwide audit of hospital admissions with COVID-19 and diabetes, from start of pandemic to November 2021. Primary outcome was inpatient mortality. DKA and HHS were adjudicated against national criteria. Age-adjusted odds ratios (ORs) were calculated using logistic regression.
Results: 85 confirmed DKA cases, and 20 HHS, occurred among 4073 people (211 type 1 diabetes, 3748 type 2 diabetes, 114 unknown type) hospitalised with COVID-19. Mean(SD) age was 60(18.2)y in DKA and 74(11.8)y in HHS (P < 0.001). A higher proportion of patients with HHS than with DKA were of non-White ethnicity (71.4% vs 39.0% P = 0.038). Mortality in DKA was 36.8% (n = 57) and 3.8% (n = 26) in type 2 and type 1 diabetes respectively. Among people with type 2 diabetes and DKA, mortality was lower in insulin users compared to non-users (21.4% vs. 52.2%; age-adjusted OR 0.13 [95%CI 0.03-0.60]). Crude mortality was lower in DKA than HHS (25.9% vs. 65.0%, P = 0.001) and in statin users vs non-users (36.4% vs. 100%; P = 0.035) but these were not statistically significant after age adjustment.
Conclusions: Hospitalisation with COVID-19 and adjudicated DKA is four times more common than HHS but both associate with substantial mortality. There is a strong association of prior insulin therapy with survival in type 2 diabetes-associated DKA. This article is protected by copyright. All rights reserved.